Qing Wen

995 total citations
38 papers, 770 citations indexed

About

Qing Wen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qing Wen has authored 38 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qing Wen's work include Cancer Immunotherapy and Biomarkers (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and HER2/EGFR in Cancer Research (4 papers). Qing Wen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and HER2/EGFR in Cancer Research (4 papers). Qing Wen collaborates with scholars based in China, United States and France. Qing Wen's co-authors include Tao Jiang, Min Long, Montserrat Rojo de la Vega, Georg T. Wondrak, Pak Kin Wong, Hongting Zheng, Donna D. Zhang, Manish Bharara, Rui Zhang and Shiwen Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Diabetes.

In The Last Decade

Qing Wen

34 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Wen China 10 320 116 108 95 84 38 770
Xuelian Chen China 16 296 0.9× 94 0.8× 141 1.3× 82 0.9× 124 1.5× 46 873
Yue Luo China 15 236 0.7× 90 0.8× 164 1.5× 41 0.4× 75 0.9× 67 761
Mengting Xu China 16 764 2.4× 41 0.4× 63 0.6× 48 0.5× 132 1.6× 45 1.1k
Venkata Ramireddy Narala India 20 571 1.8× 104 0.9× 173 1.6× 22 0.2× 131 1.6× 51 1.2k
Poliana Camila Marinello Brazil 17 300 0.9× 172 1.5× 49 0.5× 49 0.5× 64 0.8× 48 801
Min Ai China 13 212 0.7× 81 0.7× 19 0.2× 41 0.4× 34 0.4× 50 521
Soo Young Moon South Korea 15 240 0.8× 77 0.7× 47 0.4× 22 0.2× 19 0.2× 52 788
Hangming Dong China 20 508 1.6× 67 0.6× 152 1.4× 22 0.2× 98 1.2× 50 969
Michael Warso United States 12 299 0.9× 185 1.6× 70 0.6× 10 0.1× 63 0.8× 20 835
Peng Qiu China 15 330 1.0× 54 0.5× 115 1.1× 14 0.1× 54 0.6× 21 707

Countries citing papers authored by Qing Wen

Since Specialization
Citations

This map shows the geographic impact of Qing Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Wen more than expected).

Fields of papers citing papers by Qing Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Wen. The network helps show where Qing Wen may publish in the future.

Co-authorship network of co-authors of Qing Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Wen. A scholar is included among the top collaborators of Qing Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Wen. Qing Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yanyan, Xueying Wu, Yucheng Lu, et al.. (2025). Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resistance Updates. 79. 101211–101211. 5 indexed citations
2.
Wang, Xuanxuan, et al.. (2025). Effect of High‐Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants. Clinical Pharmacology in Drug Development. 14(4). 292–297.
3.
Xu, Yuanyuan, Tonghao Zhang, Qing Wen, et al.. (2025). Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment. British Journal of Clinical Pharmacology. 92(2). 476–487. 1 indexed citations
4.
Shen, Lin, Caicun Zhou, Yinghua Ji, et al.. (2024). Results of a phase 1/2 study of MHB088C: A novel B7H3 antibody-drug conjugate (ADC) incorporating a potent DNA topoisomerase I inhibitor in recurrent or metastatic solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3012–3012. 9 indexed citations
5.
Meng, Yanchun, Xiaojun Liu, Yuxin Mu, et al.. (2024). Phase I summary of the HB0025 efficacy and safety to the heavily pretreated non-small cell lung cancer (NSCLC) population.. Journal of Clinical Oncology. 42(16_suppl). e14600–e14600. 1 indexed citations
6.
Du, Yiqun, Jian Zhang, Meili Sun, et al.. (2023). Safety and efficacy of HB0025, an anti-PD-1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: Preliminary results from an FIH trial.. Journal of Clinical Oncology. 41(16_suppl). 2589–2589. 4 indexed citations
7.
Tian, Yuan, et al.. (2022). The Significance of Tumor Microenvironment Score for Breast Cancer Patients. BioMed Research International. 2022(1). 5673810–5673810. 4 indexed citations
8.
Tian, Yuan, Ran Li, Yan Liu, et al.. (2021). The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 667650–667650. 9 indexed citations
9.
Ji, Wei, et al.. (2021). Pharmacokinetic comparison of nalbuphine with single injection and patient‐controlled analgesia mimic method in healthy Chinese volunteers. Journal of Clinical Pharmacy and Therapeutics. 46(4). 1166–1172. 8 indexed citations
10.
Tian, Yuan, Alan Huang, Yue Yang, et al.. (2021). Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 4 indexed citations
11.
12.
Wang, Xian, et al.. (2020). Blood DNA methylation and type 2 diabetes mellitus. Medicine. 99(23). e20530–e20530. 3 indexed citations
13.
Tian, Yuan, Aiqin Gao, Qing Wen, et al.. (2020). Immune-Related Neurological Toxicities of PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 11. 595655–595655. 9 indexed citations
14.
Wen, Qing, et al.. (2020). Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis. Revue Neurologique. 177(6). 639–646. 6 indexed citations
15.
Wang, Jingnan, et al.. (2019). The prognostic landscape of tumor-infiltrating immune cells in cervical cancer. Biomedicine & Pharmacotherapy. 120. 109444–109444. 78 indexed citations
16.
Guo, Nan, Xiaoran Zhang, Zhan‐Qi Cao, et al.. (2017). Determination of brusatol in plasma and tissues by LC–MS method and its application to a pharmacokinetic and distribution study in mice. Journal of Chromatography B. 1053. 20–26. 10 indexed citations
17.
Qian, Zhongqing, Tong Zhou, Xiaoyan Xu, et al.. (2015). Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival. Scientific Reports. 5(1). 16889–16889. 42 indexed citations
18.
Wang, Shuai, Bai Jing-ping, Yen‐Yun Wang, et al.. (2013). Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells. Cell Death and Disease. 4(10). e856–e856. 46 indexed citations
19.
Tian, Xiuzhi, Qing Wen, Jianmin Shi, et al.. (2010). Effects of Melatonin on In Vitro Development of Mouse Two-Cell Embryos Cultured in HTF Medium. Endocrine Research. 35(1). 17–23. 48 indexed citations
20.
Wen, Qing, et al.. (1991). Sodium Regulation in the Affinity of Renal  2-Adrenoceptors for Epinephrine in Sabra Salt-Sensitive and Salt-Resistant Rats. American Journal of Hypertension. 4(3 Pt 1). 267–270. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuelian Chen Breakdown of academic impact, for papers by Yue Luo Breakdown of academic impact, for papers by Mengting Xu Breakdown of academic impact, for papers by Venkata Ramireddy Narala Breakdown of academic impact, for papers by Poliana Camila Marinello Breakdown of academic impact, for papers by Min Ai Breakdown of academic impact, for papers by Soo Young Moon Breakdown of academic impact, for papers by Hangming Dong Breakdown of academic impact, for papers by Michael Warso Breakdown of academic impact, for papers by Peng Qiu
Rankless by CCL
2026